Filing Flows › Comparisons › CYTK vs MRVI
Cytokinetics vs Maravai Lifesciences Holdings: CYTK and MRVI compared
Cytokinetics is the larger company: $47.6M of revenue in its latest quarter (Q3 2026) against $45.9M for Maravai Lifesciences Holdings (Q3 2026). Cytokinetics is growing faster (25× against +10% a year earlier). Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -351.3%.
Where the money goes: CYTK and MRVI
Cytokinetics (CYTK) · Q3 2026
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
Maravai Lifesciences Holdings (MRVI) · Q3 2026
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
| Cytokinetics (CYTK) | Maravai Lifesciences Holdings (MRVI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $47.6M | $45.9M |
| Revenue growth, Y/Y | 25× | +10% |
| Operating margin | -351.3% | -45.0% |
| Net earnings | −$190M | −$24.0M |
| Net margin | -399.7% | -52.3% |
| Operating cash flow | −$124M | $5.0M |
| Free cash flow | — | $4.5M |
| Market value | $8.4B | — |
| Analysts’ mean target | $107.22 | — |
Where the revenue comes from
Cytokinetics
- Net Product Revenue: $44.5M (94%)
- Collaboration Revenues: $3.0M (6%)
Maravai Lifesciences Holdings
- TriLink: $28.4M (62%)
- Cygnus: $17.5M (38%)
Questions
Which is bigger, Cytokinetics or Maravai Lifesciences Holdings?
Cytokinetics is the larger company: $47.6M of revenue in its latest quarter (Q3 2026) against $45.9M for Maravai Lifesciences Holdings (Q3 2026).
Is Cytokinetics or Maravai Lifesciences Holdings growing faster?
Cytokinetics is growing faster (25× against +10% a year earlier).
Which is more profitable, Cytokinetics or Maravai Lifesciences Holdings?
Maravai Lifesciences Holdings is more profitable, with an operating margin of -45.0% against -351.3%.
More: Cytokinetics earnings · how Cytokinetics makes money · Maravai Lifesciences Holdings earnings · how Maravai Lifesciences Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.